Higher strength lanthanum carbonate provides serum phosphorus control with a low tablet burden and is preferred by patients and physicians: a multicenter study (Q36843430)

From Wikidata
Jump to navigation Jump to search
scientific article published on 25 June 2008
edit
Language Label Description Also known as
English
Higher strength lanthanum carbonate provides serum phosphorus control with a low tablet burden and is preferred by patients and physicians: a multicenter study
scientific article published on 25 June 2008

    Statements

    Higher strength lanthanum carbonate provides serum phosphorus control with a low tablet burden and is preferred by patients and physicians: a multicenter study (English)
    Steven Fishbane
    Stuart M Sprague
    Fosrenol Overview Research Evaluation Study for Early Experience Study Group

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit